Share chart Cardiol Therapeutics Inc.
Extended chart
Simple chart
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. more details| IPO date | 2019-01-15 |
|---|---|
| ISIN | CA14161Y2006 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | cad |
| Сайт | https://www.cardiolrx.com |
| Цена ао | 1.15 |
| Change price per day: | 0% (1.14) |
|---|---|
| Change price per week: | -0.8696% (1.15) |
| Change price per month: | +12.87% (1.01) |
| Change price per 3 month: | -6.56% (1.22) |
| Change price per half year: | -36.31% (1.79) |
| Change price per year: | -47.71% (2.18) |
| Change price per 3 year: | +0.885% (1.13) |
| Change price per 5 year: | -42.01% (1.966) |
| Change price per year to date: | -10.94% (1.28) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| MMCAP International, Inc. SPC | 2953300 | 4.33 |
| AdvisorShares Investments, LLC | 1189978 | 1.75 |
| Tejara Capital Ltd | 1116676 | 1.64 |
| AXS Investments, LLC | 697651 | 1.02 |
| Lion Street Advisors, LLC | 192700 | 0.28 |
| Bank of Montreal/Can/ | 104479 | 0.15 |
| We Are One Seven, LLC | 100000 | 0.15 |
| Laird Norton Trust Company, LLC | 100000 | 0.15 |
| Cambridge Investment Research Advisors Inc. | 85201 | 0.12 |
| Credit Suisse Ag/ | 80000 | 0.12 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. David G. Elsley MBA | President, CEO & Director | 550.14k | |
| Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA | CFO, Corporate Secretary & Director | 216.79k | |
| Mr. Bernard Lim B.Sc. | Chief Operating Officer | 379.39k | |
| Dr. Andrew Warwick Hamer M.D. | Chief Medical Officer & Head of Research & Development | 549.01k | 1962 (63 years) |
| Trevor Burns | Investor Relations | N/A | |
| Mr. John A. Geddes BSCPT, MBA | Vice President of Corporate Development |
Address: Canada, Oakville, 2265 Upper Middle Road East - open in Google maps, open in Yandex maps
Website: https://www.cardiolrx.com
Website: https://www.cardiolrx.com
